These include the greater need for standards and physician acceptance of novel telemedicine technologies. Effective telemedicine technology will increase the number of patients that physicians treat remotely and lower the costs and travel times associated with treatment.
New analysis from Frost & Sullivan (patientmonitoring.frost.com), SAS Competitive Benchmarking of Telemedicine Vendors in Europe, finds that the European telemedicine market generated revenues of $118.0 million in 2007 and is estimated to reach $236.0 million by 2014.
"While it is apparent that the telemedicine industry is in the midst of great change, it is not clear how the industry will look in the years to come," states Frost & Sullivan Research Analyst Janani Narasimhan. "Technological developments have the potential to not only alleviate the current growing pains but also provide some solutions for the major challenges facing the business of telemedicine delivery."
The industry's technology is becoming increasingly sophisticated and powerful. At the same time, prices for computers, software and transmission equipment are falling.
"New telemedicine networks will be able to take advantage of recent improvements in telecommunications infrastructure and the growth in digital communications," Narasimhan notes. "Up and coming technological advances will have numerous applications in telemedicine."
Many market participants are looking to lower the cost of technologies to widen the deployment of telemedicine, while health organisations are increasingly using telehealth technology to monitor patients remotely. However, the lack of payer reimbursement is a major barrier to broader adoption. Moreover, the technology is believed to be extremely expensive, with questionable returns on investment.
"The high cost of operation has led to the perception among early adopters that telehealth costs must fall to nearly one-third to one-fifth of their present prices before they become widespread and easily accessible," explains Narasimhan.
Governments will be compelled to adopt certain eHealth strategies accompanied by concrete actions, if they wish to keep pace with future demands for healthcare and reduce escalating healthcare costs. As the number of households connected to the Internet grows, the number of web sites/portals dedicated to patients with specific diseases will expand as well. This trend will also increase online communication between doctors and patients, auguring well for market expansion.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the SAS competitive benchmarking of telemedicine vendors in Europe, then send an email to Patrick Cairns, Corporate Communications, at pcairns_pr[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.
SAS Competitive Benchmarking of Telemedicine Vendors in Europe is part of the Patient Monitoring Growth Partnership Services Programme, which also includes research in the following markets: European Non - Invasive Blood Pressure Monitors Market and Eastern European Blood Gas Analysers and monitors markets. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participantts. Interviews with the press are available.
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
SAS Competitive Benchmarking of Telemedicine Vendors in Europe